用于治疗II型糖尿病的新型胰高血糖素样肽1受体激动剂
Novel Glucagon-like Peptide 1 Receptor Agonists for Treating Type II Diabetes.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2024 Jul 11;15(8):1182-1183. doi: 10.1021/acsmedchemlett.4c00303. eCollection 2024 Aug 8.
Abstract
Provided herein are novel glucagon-like peptide-1 receptor agonists, pharmaceutical compositions, use of such compounds in treating type II diabetes, and processes for preparing such compounds.
摘要
本文提供了新型胰高血糖素样肽-1受体激动剂、药物组合物、此类化合物在治疗II型糖尿病中的用途以及制备此类化合物的方法。
相似文献
1
Novel Glucagon-like Peptide 1 Receptor Agonists for Treating Type II Diabetes.用于治疗II型糖尿病的新型胰高血糖素样肽1受体激动剂
ACS Med Chem Lett. 2024 Jul 11;15(8):1182-1183. doi: 10.1021/acsmedchemlett.4c00303. eCollection 2024 Aug 8.
2
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂（GLP-1 RAs）减肥效果的网状Meta分析的数量、质量及结果：一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
3
Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials.胰高血糖素样肽1（GLP-1）受体激动剂在孕期的使用：来自监管临床试验的安全性数据。
Diabetes Obes Metab. 2025 May 6. doi: 10.1111/dom.16437.
4
Novel Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and Hypersomnia.用于治疗睡眠障碍（即发作性睡病和发作性嗜睡症）的新型食欲素受体激动剂化合物。
ACS Med Chem Lett. 2024 Jul 3;15(8):1178-1179. doi: 10.1021/acsmedchemlett.4c00285. eCollection 2024 Aug 8.
5
Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic Dermatitis.用于治疗银屑病和特应性皮炎的新型芳烃受体激动剂。
ACS Med Chem Lett. 2024 Nov 14;15(12):2095-2096. doi: 10.1021/acsmedchemlett.4c00537. eCollection 2024 Dec 12.
6
Novel AHR Agonists for Treating Psoriasis and Atopic Dermatitis.用于治疗银屑病和特应性皮炎的新型芳烃受体激动剂。
ACS Med Chem Lett. 2024 Jun 21;15(7):996-997. doi: 10.1021/acsmedchemlett.4c00262. eCollection 2024 Jul 11.
7
Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes.新型氰基吡啶化合物作为治疗非酒精性脂肪性肝病、非酒精性脂肪性肝炎和II型糖尿病的KHK抑制剂
ACS Med Chem Lett. 2024 Jul 23;15(8):1191-1192. doi: 10.1021/acsmedchemlett.4c00332. eCollection 2024 Aug 8.
8
Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar Disorders.新型麦角灵化合物作为5-HT2A激动剂用于治疗情绪障碍，如抑郁症和双相情感障碍。
ACS Med Chem Lett. 2024 Dec 20;16(1):32-33. doi: 10.1021/acsmedchemlett.4c00593. eCollection 2025 Jan 9.
9
Novel Tryptamine Compounds as 5-HT2A Agonists for Treating Mood Disorders such as Depressive Disorders and Bipolar Disorders.新型色胺化合物作为5-HT2A激动剂用于治疗情绪障碍，如抑郁症和双相情感障碍。
ACS Med Chem Lett. 2025 Feb 13;16(3):373-374. doi: 10.1021/acsmedchemlett.5c00047. eCollection 2025 Mar 13.
10
Novel Pyrrolidinone Urea Compounds as FPR2 Agonists for Treating Atherosclerosis and Heart Failure.新型吡咯烷酮脲化合物作为治疗动脉粥样硬化和心力衰竭的FPR2激动剂
ACS Med Chem Lett. 2024 Nov 14;15(12):2093-2094. doi: 10.1021/acsmedchemlett.4c00536. eCollection 2024 Dec 12.
本文引用的文献
1
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.GLP-1 类药物治疗 2 型糖尿病和肥胖症的疗效和安全性。
Diabetes Care. 2024 Nov 1;47(11):1873-1888. doi: 10.2337/dci24-0003.
2
Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?口服胰高血糖素样肽-1 受体激动剂和肠促胰岛素联合治疗成人 2 型糖尿病：我们现在在哪里？
Expert Opin Pharmacother. 2024 May;25(7):801-818. doi: 10.1080/14656566.2024.2356254. Epub 2024 May 22.
3
Glucagon-like peptide-1 analogs: Miracle drugs are blooming?胰高血糖素样肽-1 类似物：“神药”正在绽放？
Eur J Med Chem. 2024 Apr 5;269:116342. doi: 10.1016/j.ejmech.2024.116342. Epub 2024 Mar 17.
4
Glucagon-like peptide agonists: A prospective review.胰高血糖素样肽激动剂：前瞻性综述。
Endocrinol Diabetes Metab. 2024 Jan;7(1):e462. doi: 10.1002/edm2.462. Epub 2023 Dec 14.
5
Novel 2,5-Diazabicyclo[4.2.0]octanes as GLP-1 Receptor Modulators for Treating Type 2 Diabetes.新型2,5-二氮杂双环[4.2.0]辛烷作为治疗2型糖尿病的胰高血糖素样肽-1受体调节剂
ACS Med Chem Lett. 2023 May 26;14(6):709-710. doi: 10.1021/acsmedchemlett.3c00196. eCollection 2023 Jun 8.
6
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists.胰高血糖素样肽-1 受体激动剂的发现和研发。
Curr Med Chem. 2024;31(20):2921-2943. doi: 10.2174/0929867330666230416153301.
Zotero 插件